# Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip

> **NCT03949673** · PHASE2 · TERMINATED · sponsor: **Regeneron Pharmaceuticals** · enrollment: 23 (actual)

## Conditions studied

- Osteoarthritis, Knee
- Osteoarthritis, Hip

## Interventions

- **DRUG:** Fasinumab
- **DRUG:** Naproxen
- **DRUG:** Diclofenac
- **DRUG:** Celecoxib
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03949673
- **Lead sponsor:** Regeneron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-04-08
- **Primary completion:** 2020-08-25
- **Final completion:** 2020-08-25
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Lack of enrollment
- **Last updated:** 2023-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03949673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03949673, "Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03949673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*